Citation Impact
Citing Papers
High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis
2008
Surgery for obesity in older women
2008
The history of echocardiography
2004
Birth Prevalence of Congenital Heart Disease Worldwide
2011 Standout
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
1988
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
1993 Standout
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Premature mortality due to cardiovascular disease in hypopituitarism
1990 Standout
Trans Polyunsaturated Fatty Acids Have More Adverse Effects than Saturated Fatty Acids on the Concentration and Composition of Lipoproteins Secreted by Human Hepatoma HepG2 Cells
2002
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Point-of-Care Ultrasonography
2011 Standout
High-Density Lipoprotein — The Clinical Implications of Recent Studies
1989
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
1994
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The Primary Prevention of Myocardial Infarction
1992
Fenofibrate
1990
Postmenopausal hormone therapy and atherosclerotic disease
1994
Polycystic Ovary Syndrome
1995 Standout
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Uterine fibroids
2001 Standout
High Density Lipoprotein Structure–Function and Role in Reverse Cholesterol Transport
2010
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-lliac atherosclerosis
1989
Effects of fibrates on serum lipids and atherosclerosis
1988
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men
2002
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
1993
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
2003 Standout
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
1990
Atherosclerosis
2000 StandoutNature
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
2016
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice
2000 Standout
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Factors affecting lipoprotein metabolism.
1965
Effects of saturated, monounsaturated, and ω-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans
1983
HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.
1991
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
1985
Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease
1984
Studies of the Composition and Structure of Serum Lipoproteins. Separation and Characterization of Phospholipid-Protein Residues Obtained by Partial Delipidization of Very Low Density Lipoproteins of Human Serum*
1966
Plasma Lipoproteins in Liver Disease: I. Immunologically Distinct Low-Density Lipoproteins in Patients with Biliary Obstruction*
1967
Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity
1974 StandoutNobel
Atherogenesis: a postprandial phenomenon.
1979 Standout
The influence of age and atherosclerosis on the chemistry of aortic intima
1965
Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review
1986
High density lipoprotein as a protective factor against coronary heart disease
1977 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Metabolic relationships among the plasma lipoproteins
1972
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3
2010
High Density Lipoprotein-2 and Hepatic Lipase: Reciprocal Changes Produced by Estrogen and Norgestrel*
1982
Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts by Lipoproteins
1973 StandoutNobel
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle.
1978 StandoutNobel
New method for partial delipidization of serum lipoproteins
1965
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins.
1972
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
1970 Standout
The plasma lecithin:cholesterol acyltransferase reaction
1968 Standout
Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Cultured Human Fibroblasts
1974 StandoutNobel
Estrogen and Coronary Heart Disease in Women
1991 Standout
Occurrence of drugs in German sewage treatment plants and rivers
1998 Standout
Small high density lipoprotein subclasses: some of their physico-chemical properties and stability in solution.
2005
Variation of postheparin plasma hepatic lipase by menstrual cycle
1986
The adaptive response of skeletal muscle to increased use
1981
Lipoprotein apoprotein metabolism.
1978
The role of deliberate practice in the acquisition of expert performance.
1993 Standout
Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.
1990
Growth hormone in the regulation of hyperlipidemia
1982
Nitrogen, Lipid, Glycogen and Deoxyribonucleic Acid Content of Human Liver
1963
Replacement of neutral lipids of low density lipoprotein with esters of long chain unsaturated fatty acids.
1979 StandoutNobel
The lipoproteins and lipid transport in abetalipoproteinemia.
1966
The nature of pre beta (very low density) lipoproteins.
1966
Etiology and management of fecal incontinence
1993 Standout
Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate
1987
Works of A. Gustafson being referenced
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen.
1979
Lipid and carbohydrate metabolism studies in oophorectomized women: Effects produced by the addition of norethisterone acetate to two estrogen preparations
1982
Human Plasma High-Density Lipoprotein Composition during the Menstrual Cycle
1974
Aspects of the Pathogenesis of Cholestasis of Pregnancy with Reference to the Serum Lipid Abnormalities
1975
A new method for partial delipidization of serum lipoproteins
1964
Studies in Cholestasis of Pregnancy
1975
Studies on Human Serum High-Density Lipoproteins
1976
Effects of a Biguanide (Metformin) on Vitamin B12and Folic Acid Absorption and Intestinal Enzyme Activities
1971
[Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
1980
Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men
1980
Ultrasoundcardiography in mitral stenosis with particular reference to the relationship to hemodynamic and surgical findings.
1966
Studies of the composition and structure of serum lipoproteins: Physical-chemical characterization of phospholipid-protein residues obtained from very-low-density human serum lipoproteins
1964
Cholesterol and Phospholipid Levels in Human Liver and Muscle in Relation to the Serum Cholesterol Level
1961
Gonadal Steroid Effects on Plasma Lipoproteins and Individual Phospholipids
1972
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens
1982
Studies in Normal Pregnancy
1975
Effects of jejuno‐ileal bypass on serum lipoproteins and glucose tolerance in severely obese patients
1980
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B.
1978